The validation study (study 2) aimed to establish the clinical performance of the developed endometriosis IVD test, combining an ELISA kit to measure serum concentrations of BDNF and CA125 and a diagnostic software hosting the diagnostic algorithm. This evidence concerns the gene BDNF and endometriosis.